Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anatomical versus non-anatomical liver resection for hepatocellular carcinoma - an international multicenter propensity score-matched analysis of short- and long-term outcomes in an international multicenter cohort.

HPB : the official journal of the International Hepato Pancreato Biliary Association·2026
Same author

Utility of the Iwate Difficulty Scoring System for the Stratification of Laparoscopic Right Hepatectomies: An International Multicenter Study.

Journal of hepato-biliary-pancreatic sciences·2026
Same author

PEPN1924, A Phase II Study of Trastuzumab Deruxtecan in Patients With Recurrent Human Epidermal Growth Factor Receptor 2+ Osteosarcoma: A Children's Oncology Group Pediatric Early-Phase Clinical Trial Network Study.

JCO oncology advances·2026
Same author

An international framework for clinical translation of molecular classifiers in osteosarcoma.

NPJ precision oncology·2026
Same author

Validation of the Southampton Difficulty Scoring System in Robotic Liver Surgery and Development of the International RoboLiver Difficulty Scoring System.

Journal of the American College of Surgeons·2026
Same author

Sociodemographics and Attrition in Children With Osteosarcoma Enrolled in the AOST0331 Clinical Trial.

JAMA network open·2026
Same journal

Peptidomics in the Spotlight: Advanced Sample Treatment Techniques and Analytical Insights.

Advances in experimental medicine and biology·2026
Same journal

Methods for the Investigation of Protein-Ligands Interactions.

Advances in experimental medicine and biology·2026
Same journal

Sample Preparation Strategies for Microbial Cell Surface Proteomics: Integrating Shaving and Shotgun Approaches.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Sample Preparation for the Petroleum Industry: A Biocorrosion Case Study.

Advances in experimental medicine and biology·2026
Same journal

Proteomic and Functional Comparison of Extracellular Vesicles from Wild-Type and Lyn-Deficient Stromal Cells.

Advances in experimental medicine and biology·2026
Same journal

Proteomic Analysis of Histone Sequence Variants and Post-translationally Modified Forms.

Advances in experimental medicine and biology·2026
See all related articles

Related Experiment Video

Updated: Apr 28, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K

HER-2 involvement in osteosarcoma.

Jonathan Gill1, David Geller, Richard Gorlick

  • 1Department of Pediatrics, Montefiore Medical Center, The Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Rosenthal 3rd Floor, Bronx, NY, USA.

Advances in Experimental Medicine and Biology
|June 14, 2014
PubMed
Summary
This summary is machine-generated.

Research on the epidermal growth factor receptor pathway in osteosarcoma, specifically HER-2, yielded conflicting results on its expression and prognostic value. This review discusses findings and therapeutic targeting strategies for osteosarcoma treatment.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.3K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

6.5K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

6.7K

Area of Science:

  • Oncology
  • Translational Research
  • Molecular Biology

Background:

  • The epidermal growth factor receptor (EGFR) pathway is crucial in various cancers.
  • HER-2 expression has been observed in a subset of osteosarcoma cases.
  • Previous research on HER-2 in osteosarcoma has produced inconsistent findings.

Purpose of the Study:

  • To review and discuss the existing literature on HER-2 expression in osteosarcoma.
  • To analyze the prognostic value of HER-2 in osteosarcoma.
  • To explore therapeutic strategies targeting the HER-2 pathway in osteosarcoma.

Main Methods:

  • Literature review and critical analysis of published studies on HER-2 in osteosarcoma.
  • Discussion of conflicting reports regarding HER-2 expression levels and prognostic significance.
  • Examination of therapeutic approaches targeting HER-2, including trastuzumab treatment.

Main Results:

  • Conflicting reports exist regarding the level and prognostic value of HER-2 expression in osteosarcoma.
  • The HER-2 pathway has been investigated as a potential therapeutic target.
  • At least one clinical study using trastuzumab for osteosarcoma treatment has been completed.

Conclusions:

  • Further research is needed to clarify the role of HER-2 in osteosarcoma.
  • Targeting the HER-2 pathway represents a potential therapeutic avenue for osteosarcoma.
  • Lessons learned from previous investigations can guide future translational research in osteosarcoma.